Recommended

Subscribers

Sign in now to see personalised content appear here.

You can also see your reading history and subscription details on your subscriber page.

Why subscribe?
Find out more.

Sign up for your FREE email newsletter  +

New

Proteomics research market reaches US$1.6bn

Instruments such as mass spectrometry, electrophoresis and liquid chromatography that can assist in the identification of drug targets and biomarker validation are in demand, reports Kalorama

Biotechnology | Measurement and Analysis

Bayer continues to invest in Indonesia

Company expands its state-of-the-art healthcare manufacturing facility at Cimanggis with €8.1m investment

Finance | Asia

Homing in on cancer targets

Traditional cancer treatments like chemo- and radiotherapy are blunt instruments. Dr Sarah Houlton looks at developments in CAR T-cell technology, which promises a much more precise approach

R and D | Therapeutic Sector

Gilead opens innovative new laboratory

Company announces additional investment in facilities to develop new drugs

Design and Build | North America | R and D | Finance

Rosa & Co. announces research agreement with Sanofi

The agreement is designed to provide greater access to the extensive depth and breadth of Rosa's expertise and foster enhanced adoption of the PhysioPD platform

R and D | Finance

Big data, big questions

Huge quantities of aggregated research and real-patient information may hold important keys for future drug discovery. Jaqui Hodgkinson, Elsevier R&D Solutions, looks at the benefits and challenges of harnessing meaningful information quickly and cost-effectively from big data

R and D | Information Technology

Pioneering a path to precision oncology through NGS

Next-Generation Sequencing is revolutionising the study of genomics and molecular biology. Thermo Fisher Scientific explains how it can be used in the design of therapeutic products with a future goal of enabling precision oncology

R and D | Biotechnology | Therapeutic Sector | Measurement and Analysis

Esco Pharma adds containment barrier isolator (CBI) range to portfolio

Suitable for a number of applications including pharmacy compounding, small-scale potent material handling and aseptic processing

Containment | Asia | Manufacturing and Equipment

Creating proactive productvigilance systems

In addition to proof of drug effectiveness, pharmacovigilance has become an important safety requirement laid down by the regulators. Dr Chitra Lele, CSO, Sciformix Corporation, discusses the importance of establishing an effective global safety framework to meet today’s needs

Manufacturing and Equipment

Off-Patent Drugs Bill could soon be back on track in UK

If draft legislation goes ahead, pharmaceutical companies will need to tread carefully, says IP law firm Withers & Rogers

Europe

Initiating change in drug development and manufacture

With R&D and production costs spiralling and the growing regulatory requirements biting into the profit margins of drug sales, the industry needs radical change to manufacturing models, argues Ed Price, President, PCI Synthesis

North America | R and D | Manufacturing and Equipment

In the Press